Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
…
continue reading
Pharma And BioTech News Podcasts
Burma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY! https://linktr.ee/maneadkhin #biotech #pharma #healthcare #podcast #petridishperspectives
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
Pharmaceutical and biotech news in 5 minutes. Drug approvals, clinical trials, and healthcare innovation.
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
…
continue reading
News and Analysis of the Biotech and Pharma Industry for Investors and Executives.
…
continue reading
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Welcome to the Ennovation Podcast, where we bring you the latest trends, insights and expertise in life sciences and regulatory affairs.
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
…
continue reading
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
…
continue reading
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
…
continue reading
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
…
continue reading
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
…
continue reading
1
Crude’s Crumble… And Why A Market Goldilocks Scenario Is Still In Play 12/16/25
43:45
43:45
Play later
Play later
Lists
Like
Liked
43:45
Crude continuing its crumble as WTI dips below $55 a barrel. The next move for the energy sector as it struggles to see any gains this year. Plus Why Jefferies’ David Zervos still sees a goldilocks scenario in play for the market as we head into year end. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inform…
…
continue reading
1
EnWave reports strong Q4 and FY2025 results as machine sales and royalties grow
3:37
3:37
Play later
Play later
Lists
Like
Liked
3:37
EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to discuss the company’s interim financial results for the fourth quarter and fiscal year ended September 30, 2025, highlighting a strong finish to the year driven by rising machine sales and expanding royalty streams.For the fourth quarter of fiscal 2025, EnWave reported re…
…
continue reading
1
Nextech3D.ai strengthens sales leadership to drive commercial growth in 2026
8:23
8:23
Play later
Play later
Lists
Like
Liked
8:23
Nextech3D.ai CEO Evan Gappelberg and the company’s newly appointed Global Head of Sales, James McGuinness, joined Steve Darling from Proactive to discuss the strategic importance of McGuinness’ appointment as the company sharpens its focus on expanding commercial operations heading into 2026.Gappelberg explained that strengthening the sales organiz…
…
continue reading
1
Medicus Pharma completes enrollment in Phase 2 skin cancer microneedle study
5:49
5:49
Play later
Play later
Lists
Like
Liked
5:49
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce another major clinical milestone for the company, confirming that enrollment has been successfully completed in its Phase 2 clinical study evaluating the safety and efficacy of its Doxorubicin Microneedle Array (D-MNA), also known as SKNJCT-003, for the non-invasive …
…
continue reading
1
C3 Metals hits broad copper mineralization in first-ever drill hole at Khaleesi
5:18
5:18
Play later
Play later
Lists
Like
Liked
5:18
C3 Metals CEO Dan Symons joined Steve Darling from Proactive to announce highly encouraging results from the first drill hole ever completed at the company’s Khaleesi copper project in southern Peru, marking a significant milestone for the greenfield exploration asset.The inaugural hole returned a broad intercept of 269.0 metres grading 0.30% coppe…
…
continue reading
1
Blue Gold secures $4.5B gold supply to launch tokenized gold strategy
9:15
9:15
Play later
Play later
Lists
Like
Liked
9:15
Blue Gold Limited CEO Andrew Cavaghan joined Steve Darling from Proactive to outline the company’s latest strategic initiatives, highlighted by a major move into the rapidly emerging tokenized gold market.Cavaghan confirmed that Blue Gold Ltd has signed a landmark agreement securing access to 1 million ounces of gold, with an estimated value of app…
…
continue reading
1
18. Putting solid tumours under the T-knife: how a next-gen TCR aims to crack them
22:44
22:44
Play later
Play later
Lists
Like
Liked
22:44
Engineered T-cell receptor (TCR) therapies promise to do for solid tumours what chimeric antigen receptor T-cell (CAR-T) therapies have done for haematological malignancies. The two approaches are conceptually similar – each involves the isolation and modification of patients’ T-cells to recognise and kill tumour cells. The main difference lies in …
…
continue reading
1
Pathos CEO Omar Hamdi on IPO, AI tech & growth strategy
8:08
8:08
Play later
Play later
Lists
Like
Liked
8:08
Pathos Communications (LSE:NEWS) CEO Omar Hamdi talked with Proactive's Stephen Gunnion about the company’s mission to revolutionise media access for small and medium-sized enterprises (SMEs) through its proprietary AI tools.Hamdi outlined how Pathos Communications solves a long-standing issue in the PR space: getting SMEs into mainstream media cov…
…
continue reading
1
Genflow Biosciences CEO discusses next steps as canine gene therapy trial hits milestone
6:47
6:47
Play later
Play later
Lists
Like
Liked
6:47
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about the company’s progress in its canine gene therapy trial targeting sarcopenia.Leire confirmed that the dosing phase has now been completed with no adverse effects, calling it a key milestone in de-risking the SIRT6 programme for potential …
…
continue reading
1
FDA Approvals Propel Oncology and Cardiovascular Innovations
7:19
7:19
Play later
Play later
Lists
Like
Liked
7:19
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into the latest breakthroughs, regulatory updates, and industry trends shaping the future of healthcare.Let's start with Johnson & Johnson's recent achievement in precision oncology. They've s…
…
continue reading
1
A Massive Charge for Ford, and the CEO of a Biotech Up Nearly 500% this Year 12/15/25
42:29
42:29
Play later
Play later
Lists
Like
Liked
42:29
Shares of Ford on the move after the automaker announced a $19.5b write off of its electric vehicle business. What the company is focusing on now, instead. Plus Terns Pharmaceuticals announced positive results for its new cancer drug last week. The CEO joins to lay out next steps for the company. Fast Money Disclaimer Hosted by Simplecast, an AdsWi…
…
continue reading
1
HIVE Digital hits 25 Exahash milestone with green energy
4:33
4:33
Play later
Play later
Lists
Like
Liked
4:33
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) executive chairman Frank Holmes talked with Proactive's Stephen Gunnion about the company's progress in both its Bitcoin mining operations and AI HPC initiatives.Holmes highlighted that the company has scaled its Bitcoin hash rate from 6 to 25 exahash over six months, a significant milestone that …
…
continue reading
1
Pinnacle Silver & Gold CEO on signficance of first undergound drill program at El Potrero
4:36
4:36
Play later
Play later
Lists
Like
Liked
4:36
Pinnacle Silver & Gold Corp (TSX-V:PINN, OTCQB:PSGCF) CEO Robert Archer talked with Proactive's Stephen Gunnion about the company's first drill program at the El Potrero project in Mexico, which will start with underground drilling rather than surface work.Archer explained that the underground access available at El Potrero, due to historic mining …
…
continue reading
1
RenoWorks Software grows recurring revenue with AI tools for home design platform
5:23
5:23
Play later
Play later
Lists
Like
Liked
5:23
RenoWorks Software Inc (TSX-V:RW, OTC:ROWKF) CEO Doug Vickerson talked with Proactive's Stephen Gunnion about the company’s continued growth and investment focus as it expands its AI-powered home design platform.Vickerson outlined how RenoWorks is helping users, including homeowners, contractors, and manufacturers, virtually remodel their homes usi…
…
continue reading
1
OS Therapies targets January BLA filing for OST-HER2 following successful Type C meeting with FDA
7:39
7:39
Play later
Play later
Lists
Like
Liked
7:39
OS Therapies Inc (NYSE-A:OSTX) chief business officer Gerald Commissiong talked with Proactive's Stephen Gunnion about the company’s recent regulatory progress for its OST-HER2 immunotherapy platform targeting osteosarcoma. Commissiong detailed how OS Therapies acquired rights to a listeria-based therapy originally developed by Advaxis and how this…
…
continue reading
Greengage & Co Group Plc founder and CEO Sean Kiernan talked with Proactive's Stephen Gunnion about the company's plans to float on the Access segment of the Aquis Growth Market and its unique Bitcoin yield reserve strategy.Kiernan explained how Greengage, a fintech platform offering accounts and lending services, is addressing challenges faced by …
…
continue reading
1
Great Southern Copper CEO on recent high-grade hits at Chile project; 2026 driling plan
6:33
6:33
Play later
Play later
Lists
Like
Liked
6:33
Great Southern Copper PLC (LSE:GSCU) chief executive Sam Garrett talked with Proactive's Stephen Gunnion about the latest high-grade drilling results at the Cerro Negro project, with a focus on the Mostaza target area. Garrett said recent intercepts confirmed the presence of stacked lenses, potentially increasing the size and value of the copper-si…
…
continue reading
1
Chariot CFO on renewables push as funding is secured for SA wind projects
5:46
5:46
Play later
Play later
Lists
Like
Liked
5:46
Chariot Ltd (AIM:CHAR, OTC:OIGLF) chief financial officer Julian Maurice-Williams talked with Proactive's Stephen Gunnion about two key announcements tied to the company’s renewable energy operations in South Africa.The first announcement covers the financial close of two large-scale wind power projects — Zen (100MW) and Bergriver (94MW) — both loc…
…
continue reading
1
S&U chairman: motor finance momentum to continue following strong Q3
4:49
4:49
Play later
Play later
Lists
Like
Liked
4:49
S&U PLC (LSE:SUS) chairman Anthony Coombs talked with Proactive's Stephen Gunnion about the company's strong growth in the third quarter of 2025 and the outlook for 2026, particularly across its Advantage and Aspen businesses. Coombs said he expects further momentum in 2026, even if the broader economy remains flat, due to increasing market share a…
…
continue reading
1
Revolutionizing Insurance for High-Cost Gene Therapies
6:12
6:12
Play later
Play later
Lists
Like
Liked
6:12
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the exciting, yet challenging, landscape of gene therapies and their potential to revolutionize healthcare. Recent scientific advancements have pushed the boundaries of what’s possible, offering p…
…
continue reading
1
Broadcom, Oracle Lead Tech Lower, and Pot Stocks Light Up 12/12/25
43:28
43:28
Play later
Play later
Lists
Like
Liked
43:28
Shares of Broadcom and Oracle suffer from “AI Angst” to end the week, taking a bite out of tech stocks and the broader market. Plus news President Trump will soon reclassify marijuana as a much less-regulated Schedule III drug sending shares of pot stocks sharply higher. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswiz…
…
continue reading
1
Geomega Resources: building a royalty model with innovative extraction technologies
7:00
7:00
Play later
Play later
Lists
Like
Liked
7:00
Geomega Resources (TSX-V:GMA) CEO Kiril Mugerman talked with Proactive's Stephen Gunnion about the company’s bauxite residue technology and its potential global impact. In the interview, Mugerman explained how Geomega is addressing the 200 million tonnes of bauxite residue generated annually, with over 4.5 billion tonnes currently stored globally.H…
…
continue reading
1
Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach
38:47
38:47
Play later
Play later
Lists
Like
Liked
38:47
In this episode we sit down with Martin Beck, Senior Vice President and Head of the Inflammation Business Unit at Boehringer Ingelheim. Martin grew up just down the road from the company’s headquarters in Germany, joined as a scholarship student more than 20 years ago, and never really left – and you’ll hear why he still loves it. We spend most of …
…
continue reading
1
Breakthroughs and Challenges: Eli Lilly's Obesity Drug Triumphs
6:44
6:44
Play later
Play later
Lists
Like
Liked
6:44
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a myriad of transformative advancements and strategic shifts within these industries, illustrating the profound impact of innovation and regulatory changes on healthcare.Eli Lilly's recent strides…
…
continue reading
1
Fast Money Live! The Desk Trades the Holidays as the S&P and Dow Close at Records 12/11/25
46:17
46:17
Play later
Play later
Lists
Like
Liked
46:17
In our last Fast Money Live event of the year, the traders dig into Broadcom and Lululemon earnings, as well as Disney’s deal with Open AI. Plus, we’re answering our biggest fans’ most burning investing questions, and bringing you a couple holiday surprises! Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inf…
…
continue reading
1
381: The future of American science and a dispatch from ASH
33:26
33:26
Play later
Play later
Lists
Like
Liked
33:26
How did Terns Pharmaceuticals and its “hodgepodge” pipeline grab attention at the American Society of Hematology conference? Is Eli Lilly’s new drug making people lose too much weight? And what, exactly, is the Trump administration’s plan for reforming the National Institutes of Health? First, we discuss all things ASH, particularly Tern’s chronic …
…
continue reading
1
Sintana advances Challenger deal, updates Orange Basin exploration plans
7:00
7:00
Play later
Play later
Lists
Like
Liked
7:00
Sintana Energy CEO Robert Bose joined Steve Darling from Proactive to discuss the company’s progress on two major fronts: the advancement of its acquisition of Challenger and new developments across key blocks in Namibia’s Orange Basin.Bose reported that the planned acquisition of Challenger has now satisfied several significant conditions, includi…
…
continue reading
1
Aftermath Silver launches new drill programs at Berenguela and Challacollo projects
3:08
3:08
Play later
Play later
Lists
Like
Liked
3:08
Aftermath Silver CEO Ralph Rushton joined Steve Darling from Proactive to announce the commencement of a new, targeted follow-up drilling campaign at the company’s flagship Berenguela silver-copper-manganese project in southern Peru. The program includes approximately 4,000 metres of diamond core drilling and 2,000 metres of reverse circulation (RC…
…
continue reading
1
Delta Gold Technologies CEO on quantum computing, nano-scale gold and Aquis IPO
7:28
7:28
Play later
Play later
Lists
Like
Liked
7:28
Delta Gold Technologies PLC (AQSE:DGQ) CEO Michael Jones joined Stephen Gunnion in the Proactive studio to discuss more about the company’s innovative approach to quantum computing, underpinned by its nanoscale gold-based technology.Jones explained that while many firms claim to have quantum computers, the core challenge of creating stable and scal…
…
continue reading
1
Ilika CEO on end-of-year milestone: 10Ah Goliath battery prototypes shipped on schedule
4:22
4:22
Play later
Play later
Lists
Like
Liked
4:22
Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy talked with Proactive's Stephen Gunnion about a significant milestone for the company as it successfully shipped its 10Ah Goliath battery prototypes on schedule. Purdy noted that the delivery reflects the company's commitment to meeting expectations and keeping to its timelines.The prototypes will n…
…
continue reading
1
Fineqia: crypto ETPs show resilience despite market drop
9:50
9:50
Play later
Play later
Lists
Like
Liked
9:50
Fineqia International Inc (CSE:FNQ) senior associate Matteo Greco talked with Proactive's Stephen Gunnion about the key takeaways from the firm’s November report on crypto exchange-traded products (ETPs), which tracked a 17% drop in crypto assets – closely aligned with a broader 16% market decline. Despite the downturn, Greco noted that outflows fr…
…
continue reading
Send us a text In this episode of Petri Dish Perspectives, we dive deep into the remarkable evolution of Novartis, one of the world’s most influential and scientifically ambitious pharmaceutical companies. From its 18th-century dye-making origins to its modern dominance in gene therapy, oncology, and complex biologics, Novartis has become a case st…
…
continue reading
1
Optima Health CEO: 'great demand' fuels 17% revenue growth and M&A push
5:46
5:46
Play later
Play later
Lists
Like
Liked
5:46
Optima Health PLC (AIM:OPT) chief executive Jonathan Thomas talked with Proactive's Stephen Gunnion about the company’s strong first half performance, posting 17% revenue growth. Thomas credited both organic expansion and recent M&A activity, including the acquisitions of Cognate Health in Ireland and Care first, as key contributors.“The market bac…
…
continue reading
1
Transformative Breakthroughs in Cancer and Gene Therapy
7:01
7:01
Play later
Play later
Lists
Like
Liked
7:01
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In the ever-dynamic landscape of these industries, recent advancements have underscored both the scientific ingenuity and strategic foresight shaping patient care today.Pfizer has unveiled promising clinical trial dat…
…
continue reading
1
S&P Closes in on a New Record After the Fed Cut and Oracle Drops after Earnings 12/10/25
46:15
46:15
Play later
Play later
Lists
Like
Liked
46:15
The Federal Reserve cutting rates by a quarter point, as expected, at its last meeting of the year, and stocks rose on the news, with the S&P finishing the day just shy of a record. Meanwhile Oracle shares were dropping after its latest earnings report. The traders dive into all the details from the call. Fast Money Disclaimer Hosted by Simplecast,…
…
continue reading
1
MustGrow reports strong yield and revenue gains from TerraSante™ in U.S. potato trials
4:13
4:13
Play later
Play later
Lists
Like
Liked
4:13
MustGrow Biologics Corp Chief Operating Officer Colin Bletsky joined Steve Darling from Proactive to announce outstanding performance results for the company’s organic TerraSante™ biofertility product, based on large-scale customer performance data from commercial potato operations in Washington State and Idaho. The results demonstrate meaningful i…
…
continue reading
1
Temas advances La Blache project and RCL metallurgical technology with strong funding in place
5:51
5:51
Play later
Play later
Lists
Like
Liked
5:51
Temas Resources CEO Tim Fernback joined Steve Darling from Proactive to provide an update on the continued advancement of the company’s La Blache Property in Quebec, along with significant progress on its proprietary metallurgical technology initiatives. Fernback outlined Temas’ unique dual-business model, explaining that the company operates both …
…
continue reading
1
Pioneering Biosensors for Continuous Medical Monitoring with Profusa CEO Dr. Ben Hwang
47:01
47:01
Play later
Play later
Lists
Like
Liked
47:01
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Ben Hwang, PhD, Chairman and CEO of Profusa, Inc., a company developing a platform of new generation bioengineered, biointegrated sensors for the real-time, continuous monitoring of body chemistry for chronic disease m…
…
continue reading
1
Scancell’s iSCIB1+ shows 74% PFS in melanoma trial
4:48
4:48
Play later
Play later
Lists
Like
Liked
4:48
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) CEO Phillip L’Huillier talked with Proactive's Stephen Gunnion about new clinical data from its phase two melanoma study, known as the SCOPE trial, featuring its lead ImmunoBody candidate, iSCIB1+.L’Huillier highlighted that the trial has achieved the objectives set out for it, confirming the parameters f…
…
continue reading
1
Surat & Sacramento: Australian Oil expands in the US and Australia
5:47
5:47
Play later
Play later
Lists
Like
Liked
5:47
Australian Oil Company Limited (ASX:AOK) managing director Kane Marshall talked with Proactive's Stephen Gunnion about the company’s diversified strategy across gas and oil markets in both the United States and Australia.Marshall outlined the company's expansion in the Sacramento Basin in California, where it has increased its working interest with…
…
continue reading
1
Jupiter Origin: investing in global small caps
10:00
10:00
Play later
Play later
Lists
Like
Liked
10:00
Jupiter Asset Management lead investment manager Tarlock Randhawa joined Stephen Gunnion the Proactive studio to discuss the investment case for global smaller companies included in the Jupiter Origin Global Smaller Companies Active UCITS ETF (JOGS) and the approach taken by the Jupiter Origin team.Randhawa outlined the structural advantages of inv…
…
continue reading
1
Revolutionizing Drug Development: Key Industry Breakthroughs
7:36
7:36
Play later
Play later
Lists
Like
Liked
7:36
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of transformative events shaping the future of drug development, patient care, and global healthcare strategies.**Johnson & Johnson's Multiple Myeloma Advances** Johnson & Johnson has made…
…
continue reading
1
JPMorgan Warning Sends Shares Sinking, and a Pairs Trade in the Retail Space 12/9/25
43:43
43:43
Play later
Play later
Lists
Like
Liked
43:43
JPMorgan shares closed near their lows of the day after its consumer banking head said expenses would be 10% higher next year. The implications for the banking sector and the broader market. Plus Walmart shares are trading near a $1 trillion valuation. But one top technician says he’s still long the name. Fast Money Disclaimer Hosted by Simplecast,…
…
continue reading
1
Millennial Potash advances Gabon Project as global supply pressures grow
7:58
7:58
Play later
Play later
Lists
Like
Liked
7:58
Millennial Potash Chairman Farhad Abasov joined Steve Darling from Proactive to discuss the global potash supply landscape and the company’s continued progress on its flagship potash project in Gabon. Abasov highlighted the strategic importance of potash as a critical input for global food security and underscored the vulnerabilities faced by count…
…
continue reading
1
Nextech3D.ai to acquire KraftyLabs to build leading end-to-end AI event platform
7:31
7:31
Play later
Play later
Lists
Like
Liked
7:31
Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce that the company has signed a definitive agreement to acquire KraftyLabs, an AI-powered virtual and in-person event engagement platform serving a global enterprise client base. KraftyLabs’ customers include major technology and multinational brands such as Google, Netf…
…
continue reading
1
Ariana Resources MD on A$8m equity injection for Dokwe gold project in Zimbabwe
4:55
4:55
Play later
Play later
Lists
Like
Liked
4:55
Ariana Resources PLC (AIM:AAU, ASX:AA2) managing director Kerim Sener talked with Proactive's Stephen Gunnion about a new A$8 million equity investment deal that will help fund the Definitive Feasibility Study (DFS) at the Dokwe gold project in Zimbabwe.Sener explained that the investment is coming from Hongkong Xinhai Mining Services, a Chinese EP…
…
continue reading
1
IXICO CEO on 2025 results & 2026 growth outlook
5:53
5:53
Play later
Play later
Lists
Like
Liked
5:53
IXICO PLC (LSE:IXI, OTC:PHYOF) CEO Bram Goorden takes Proactive's Stephen Gunnion through the company’s full-year 2025 results and its outlook for 2026.Goorden confirmed a 13% increase in revenue to £6.5 million, driven by diversification into new trials in Alzheimer’s and Parkinson’s disease, contract extensions with existing clients, and expansio…
…
continue reading
1
Revolutionizing Hemophilia and Epilepsy Treatments: Key Developments
6:11
6:11
Play later
Play later
Lists
Like
Liked
6:11
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling advancements and challenges that are shaping this dynamic industry.Pfizer has recently unveiled phase 3 results for its hemophilia drug Hympavzi, positioning it as a formida…
…
continue reading
1
The Global Rate Rise and the Battle for Warner Bros. Discovery. 12/8/25
42:27
42:27
Play later
Play later
Lists
Like
Liked
42:27
Yields around the world are on the rise as global central banks weigh whether to cut rates before year-end. What this means for the markets, and whether there are more cuts to come. Plus a hostile bid from Paramount Skydance. But will Warner Bros. shareholders side with David Ellison’s company or Netflix. The future of the streaming landscape and t…
…
continue reading
